VolCT - Group 1A: Difference between revisions

From QIBA Wiki
Jump to navigation Jump to search
No edit summary
Line 1: Line 1:
==Current Goals & Status:==
* Goal: Benchmark intra/inter-reader variability for lung nodule volume measurements
** Status: Most of Dataset acquired; finalizing reader software
** Related Profile:
== Work Documents ==
*[[Vol-CT - 1A Group Call Summaries]]
*[[Vol-CT - 1A Group Call Summaries]]
*[[Media:Qiba-nxp-ProposedPhase1A-2008-11-13-v05.ppt|Proposed 1A Protocol Outline (2008-11-13-v05)- For Comment from QIBA Members]]
*[[Media:Qiba-nxp-ProposedPhase1A-2008-11-13-v05.ppt|Proposed 1A Protocol Outline (2008-11-13-v05)- For Comment from QIBA Members]]
== Projects ==
''May want to split these out to separate pages later''
===VolCT Lung Anthropomorphic Phantom Study===
====Objective: ====
Measure intra- & inter-reader bias and variability phantom lesions for:
:* Uni-dimensional size measurement
:* Semi-automatic 3D volumetric measure
May compare with fully automated algorithm(s)
====Dataset:====
Ground truth has been established by physical measurement "ex vivo“ on FDA phantom inserts.
Nodules (10 attached nodules)
:* -10 & +100HU
:* 10, 20 mm spheres
:* 10 mm ovoid, lobulated, spiculated
Image Dataset
:* 100 mAs exposures
:* 0.75 & 5.0 mm slices
:* 1 recon kernel
:* Status:
:** mostly acquired by FDA/CDRH/OSEL.
:** Missing: 10 mm ovoid, spic, lob (Est: 12/01/08)
Acquisition Protocol:
:* Scanner: Philips 16 slice
:* Exposure (120 kVp): 100 mAs
:* Slice thickness (50% overlap): 0.75 & 5.0 mm slices
:* Recon kernel: Standard/medium (Still on table: Detail/Lung kernel)
:* Pitch: 1.2
:* 2 repeat scans
:* 40 segmentations in set
The study is being conducted as a pilot.  The size (data, readers) has not been selected for any specific level of significance.
====Study Protocol:====
Expert readers will measure/estimate nodule size from CT images.
Readers: 6 RadPharm radiologists
Software:
:* ''Wendy will visit RadPharm and provide more info next week''
:* In-house review software (Siemens?)
:** Semi-automated 3D volume software
:** Uni-dimensional measure (RESIST)
:* ''Which fully automated software?''
Reading Session:
:* Readers read all cases in 2 different reading sessions
:** Random ordering
:*** One-dimensional measure
:*** Semi-automated segmentation
:** Sessions separated by 3 week(?)
:** Include duplicate cases within each read session (1/3-1/2 of cases for intra-reader estimates)
:* Time restrictions:  Probably not (?)
:* Specific instructions:  Probably not (?)
====Analysis:====
Estimate intra- and inter-reader variability in the different volume estimate
:* Estimate bias from known truth
:* Estimate variability
Compare the bias and variability with the different methods
====Outstanding Issues:====

Revision as of 22:38, 11 December 2008

Current Goals & Status:

  • Goal: Benchmark intra/inter-reader variability for lung nodule volume measurements
    • Status: Most of Dataset acquired; finalizing reader software
    • Related Profile:


Work Documents

Projects

May want to split these out to separate pages later

VolCT Lung Anthropomorphic Phantom Study

Objective:

Measure intra- & inter-reader bias and variability phantom lesions for:

  • Uni-dimensional size measurement
  • Semi-automatic 3D volumetric measure

May compare with fully automated algorithm(s)

Dataset:

Ground truth has been established by physical measurement "ex vivo“ on FDA phantom inserts.

Nodules (10 attached nodules)

  • -10 & +100HU
  • 10, 20 mm spheres
  • 10 mm ovoid, lobulated, spiculated

Image Dataset

  • 100 mAs exposures
  • 0.75 & 5.0 mm slices
  • 1 recon kernel
  • Status:
    • mostly acquired by FDA/CDRH/OSEL.
    • Missing: 10 mm ovoid, spic, lob (Est: 12/01/08)

Acquisition Protocol:

  • Scanner: Philips 16 slice
  • Exposure (120 kVp): 100 mAs
  • Slice thickness (50% overlap): 0.75 & 5.0 mm slices
  • Recon kernel: Standard/medium (Still on table: Detail/Lung kernel)
  • Pitch: 1.2
  • 2 repeat scans
  • 40 segmentations in set

The study is being conducted as a pilot. The size (data, readers) has not been selected for any specific level of significance.

Study Protocol:

Expert readers will measure/estimate nodule size from CT images.

Readers: 6 RadPharm radiologists

Software:

  • Wendy will visit RadPharm and provide more info next week
  • In-house review software (Siemens?)
    • Semi-automated 3D volume software
    • Uni-dimensional measure (RESIST)
  • Which fully automated software?

Reading Session:

  • Readers read all cases in 2 different reading sessions
    • Random ordering
      • One-dimensional measure
      • Semi-automated segmentation
    • Sessions separated by 3 week(?)
    • Include duplicate cases within each read session (1/3-1/2 of cases for intra-reader estimates)
  • Time restrictions: Probably not (?)
  • Specific instructions: Probably not (?)

Analysis:

Estimate intra- and inter-reader variability in the different volume estimate

  • Estimate bias from known truth
  • Estimate variability

Compare the bias and variability with the different methods

Outstanding Issues: